Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022 – GlobeNewswire

Share Article

| Source: Aleafia Health Inc. Aleafia Health Inc.
Concord, Ontario, CANADA
TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) — Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) announces that the Toronto Stock Exchange (“TSX”) issued a decision today to extend its delisting review period until November 29, 2022. The Company will provide further updates as warranted.

For Investor & Media Relations:
Matthew Sale, CFO
[email protected]
About Aleafia Health:
The Company is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort